5-149505494-T-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001892.6(CSNK1A1):c.959A>T(p.Gln320Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
CSNK1A1
NM_001892.6 missense
NM_001892.6 missense
Scores
2
4
13
Clinical Significance
Conservation
PhyloP100: 7.67
Genes affected
CSNK1A1 (HGNC:2451): (casein kinase 1 alpha 1) Enables protein serine/threonine kinase activity. Involved in several processes, including negative regulation of canonical Wnt signaling pathway; peptidyl-serine phosphorylation; and positive regulation of proteasomal ubiquitin-dependent protein catabolic process. Located in centrosome; cytosol; and nuclear speck. Part of beta-catenin destruction complex. Colocalizes with keratin filament and mRNA cleavage and polyadenylation specificity factor complex. Biomarker of Alzheimer's disease and inclusion body myositis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23237333).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSNK1A1 | NM_001892.6 | c.959A>T | p.Gln320Leu | missense_variant | 9/10 | ENST00000377843.8 | NP_001883.4 | |
CSNK1A1 | NM_001025105.3 | c.1043A>T | p.Gln348Leu | missense_variant | 10/11 | NP_001020276.1 | ||
CSNK1A1 | NM_001271741.2 | c.959A>T | p.Gln320Leu | missense_variant | 9/10 | NP_001258670.1 | ||
CSNK1A1 | NM_001271742.2 | c.776A>T | p.Gln259Leu | missense_variant | 9/10 | NP_001258671.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.1043A>T (p.Q348L) alteration is located in exon 10 (coding exon 10) of the CSNK1A1 gene. This alteration results from a A to T substitution at nucleotide position 1043, causing the glutamine (Q) at amino acid position 348 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T;T;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;.;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.;.;.;.;.
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;N;N;N;.;N;.
REVEL
Benign
Sift
Benign
T;T;T;T;.;T;.
Sift4G
Benign
T;T;T;T;T;T;T
Polyphen
0.0010, 0.0, 0.72, 0.79
.;B;B;P;.;P;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0468);Loss of solvent accessibility (P = 0.0468);.;.;.;.;.;
MVP
MPC
3.0
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.